Results 1 to 10 of about 2,598,104 (298)

Acknowledgement to Reviewers of Antibodies in 2018

open access: yesAntibodies, 2019
Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers. [...]
Antibodies Editorial Office
doaj   +2 more sources

Acknowledgement to Reviewers of Antibodies in 2013

open access: yesAntibodies, 2014
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Antibodies Editorial Office
doaj   +2 more sources

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

open access: yesFrontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling   +6 more
doaj   +1 more source

Single-Cell Technologies for the Study of Antibody-Secreting Cells

open access: yesFrontiers in Immunology, 2022
Antibody-secreting cells (ASC), plasmablasts and plasma cells, are terminally differentiated B cells responsible for large-scale production and secretion of antibodies.
Matteo Broketa   +2 more
doaj   +1 more source

Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

open access: yesFrontiers in Immunology, 2016
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek   +7 more
doaj   +1 more source

Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus

open access: yesBiomedicines
Therapeutic antibodies (Abs) which act on a broader range of epitopes may provide more durable protection against the genetic drift of a target, typical of viruses or tumors.
Ilse Roodink   +20 more
doaj   +1 more source

Catch of the Day: New Serum Amyloid A (SAA) Antibody Is a Valuable Tool to Study Fish Health in Salmonids

open access: yesCells, 2023
Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage.
Ralfs Buks   +6 more
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2017

open access: yesAntibodies, 2018
Peer review is an essential part in the publication process, ensuring that Antibodies maintains high quality standards for its published papers.[...]
Antibodies Editorial Office
doaj   +1 more source

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

open access: yesFrontiers in Immunology, 2020
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients.
Morgane Denis   +6 more
doaj   +1 more source

LICHEN enables light-chain immunoglobulin sequence generation conditioned on the heavy chain and experimental needs

open access: yesCommunications Biology
In developing therapeutic antibodies, the heavy chain is often prioritised due to its higher variability and its central role in antigen binding. An appropriate pairing of the light sequence is however important for antibody function.
Henriette L. Capel   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy